马来酸曲美布汀结合酪酸梭菌活菌片治疗肠易激综合征的临床疗效观察

Abstract
Figure/Table
References
Related Citation (0)

Download: PDF (655 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To observe the irritable patients with a combination of trimebutine maleate with Clostridium butyricum tablets the clinical effect of treatment of irritable bowel syndrome. Methods in 182 cases as the research object,randomly divided into observation group（n=92）and control group（n=90）,were treated with basic treatment in all the patients after admission,the control group treated with trimebutine treatment in the observation group,the control group on the basis of Clostridium butyricum and treatment,the incidence of clinical efficacy and adverse reactions of two groups were observed in patients with clinical symptoms. Results After treatment,the recovery time of diarrhea,abdominal pain and recovery time of stool were significantly earlier than the control group（P<0.01）.The total effective rate of the observation group（90.22%）was significantly higher than that of the control group（76.67%）（P<0.05）.There was no significant difference in the incidence of adverse reactions（5.43%）between the observation group and the adverse reactions（7.77%）in the control group（P>0.05）. Conclusion The combination of trimebutine maleate and Clostridium butyricum in the treatment of irritable bowel syndrome can effectively alleviate the symptoms of diarrhea and abdominal pain,improve stool characteristics,have significant clinical effects,and has high drug safety.It can be used as a clinical treatment.One of the common treatment options for irritable bowel syndrome.

Key words： Trimebutine maleate Clostridium butyricum tablets Irritable bowel syndrome

Received: 21 October 2020

PACS:

R574.4

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	Chen Yu

Cite this article:

Chen Yu. To Observe the Clinical Efficacy of Trimebutine Maleate Combined With Clostridium Butyricum Tablets in the Treatment of Irritable Bowel Syndrome[J]. journal1, 2021, 41(6): 13-15.

URL:

http://www.hrbyybjb.org.cn/EN/ OR http://www.hrbyybjb.org.cn/EN/Y2021/V41/I6/13

[1] 王静. 补中益气颗粒联合曲美布汀治疗脾胃虚弱证腹泻型肠易激综合征的疗效观察[J].现代药物与临床,2017,32(2):284-288.
[2] 谢宁,李曼,唐鄂.胆舒胶囊联合酪酸梭菌活菌片治疗肠易激综合征的临床疗效[J].中国新药与临床杂志,2018,37(11):651-654.
[3] Jeffery IB,O'Toole PW,Ohman L,et al.An irritable bowel syndrome Subtype definded bspecies-specific alterations infaecal microbiota[J].Gut,2012,61(7):997-1006.
[4] 李军祥. 肠易激综合征中西医结合诊疗共识意见(2017年)[J].中国中西医结合消化杂志,2018,26(3):227-232.
[5] 李树华,张红梅,梁艳旭,等.阿戈美拉汀联合马来酸曲美布汀治疗肠易激综合征临床疗效观察[J].天津医科大学学报,2016,22(6):534-536.
[6] 傅丽霞. 双歧杆菌四联活菌片治疗腹泻型肠易激综合征患者的疗效及对血清脑肠肽水平的影响[J].中国微生态学杂志,2017,29(2):179-181.
[7] 校彦勇,王荣鑫,王琳.美沙拉嗪联合马来酸曲美布汀对肠易激综合征患者的影响[J].实用中西医结合临床,2020,20(1):1-2.
[8] 陈光华,李红君,舒波.痛泻四神汤联合马来酸曲美布汀与谷维素对腹泻型肠易激综合征患者血清IFN-γ,5-HT,NPY水平及T淋巴细胞亚群的影响[J].中国中西医结合消化杂志,2018,26(9):742-746.
[9] 王菁,毕宁,方亮.参倍固肠胶囊联合马来酸曲美布汀治疗腹泻型肠易激综合征的临床研究[J].现代中西医结合杂志,2020,29(7):770-774.
[10] Moayyedi P,Ford AC,Ta11ey NJ,et a1.The efficacy of probiotics in the treatment of irritable bowel syndrome:a systematic reviewr[J].Gut,2010,59(3):325-332.
[11] 江学良,姜开通,许刚.酪酸梭菌活菌胶囊治疗腹泻型肠易激综合征的临床疗效及卫生经济学评价[J].中国微生态学杂志,2016,28(9):1075-1079.
[12] 张慧,万坚,陆芳,等.美沙拉嗪联合马来酸曲美布汀治疗肠易激综合征患者的临床疗效观察[J].国际消化病杂志,2017,37(2):95-99.
[13] 贾晨,戚凤君,张涛,等.马来酸曲美布汀联合歧杆菌三联活菌肠溶对肠易激综合征患者的疗效分析[J].重庆医学,2017,46(29):4159-4161.
[14] 刘敏,吴运.益生菌联合马来酸曲美布汀治疗便秘型肠易激综合征的疗效分析[J].国际消化病杂志,2017,37(6):377-381.
[15] 张方,李文杰.中西医结合治疗腹泻型肠易激综合征临床疗效观察[J].中医临床研究,2016,8(8):71-72.